Anemia  >>  cyclosporin A microemulsion 
Welcome,         Profile    Billing    Logout  

10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporin A microemulsion / Generic mfg.
NCT02745717: The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia

Completed
4
60
RoW
Thymoglobulin, Thymoglobuline, Cord blood, Cyclosporine Oral Product, cyclosporine A
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Tongji Hospital, Tongji University School of Medicine, Zhejiang Provincial Hospital of TCM
Severe Aplastic Anemia
12/21
12/21
NCT06525948: Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

Not yet recruiting
4
54
RoW
rhTPO, Cyclosporin A
Peking Union Medical College Hospital
Aplastic Anemia, Transfusion-dependent Anemia
06/25
12/25
2006-006577-25`ACTRN12615000820505: A prospective randomized study comparing rapamune and tacrolimus vs. cyclosporine and methotrexate as immune prophylaxis in allogeneic hematopoietic stem cell transplantation, using HLA-A, -B, -DRB1 identical related or unrelated donors. A Nordic multicenter study.

Ongoing
3
200
Europe
Rapamune, Prograf, Sandimmun Neoral, Methotrexate, Rapamune, Prograf, Sandimmun Neoral, Methotrexate, Rapamune, Prograf, Sandimmun Neoral, Methotrexate
Karolinska Institutet, Nordic Bone Marrow Transplant Group (NBMT), Federation University
Stress, Anxiety, Depression
 
 
NCT04328727: Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Active, not recruiting
2
36
Japan, RoW
eltrombopag, ETB115, rabbit anti-thymocyte globulin (r-ATG), r-ATG, cyclosporine A (CsA), CsA
Novartis Pharmaceuticals
Severe Aplastic Anemia (SAA)
06/22
12/24
NCT00719888: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Active, not recruiting
2
135
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Double-Unit Umbilical Cord Blood Transplantation, Fludarabine, 118218, Fluorovidarabine, Laboratory Biomarker Analysis, Mycophenolate Mofetil, Cellcept, MMF, Total-Body Irradiation, Total Body Irradiation, Whole-Body Irradiation, SCT_TBI, TBI, Umbilical Cord Blood Transplantation, Cord Blood Transplantation, UCB transplantation, Thiotepa, 1,1',1"-phosphinothioylidynetrisaziridine, 1,1',1''-Phosphinothioyldynetrisaziridine, 52-24-4, 6396, Girostan, Triethylenethiophosphoramide, Triethylene Thiophosphoramide
Fred Hutchinson Cancer Center
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Burkitt Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Follicular Lymphoma, Lymphoblastic Lymphoma, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Prolymphocytic Leukemia, Refractory Anemia, Small Lymphocytic Lymphoma
12/23
12/24
NCT01659606: Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Active, not recruiting
2
40
Europe, US
alemtuzumab, Campath-1H, Fludarabine, Fludara, Cyclosporins, cyclosporine A, Neoral, Sandimmune, Mycophenolate mofetil, Cellcept, Tacrolimus, FK506, Prograf
Boston Children's Hospital, Dana-Farber Cancer Institute, Children's Hospital Medical Center, Cincinnati, Children's Hospital Los Angeles, Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Baylor College of Medicine, Children's Hospital of Philadelphia, University of Wisconsin, Madison, Karolinska University Hospital, Hackensack Meridian Health, Duke University, Oslo University Hospital, Children's Mercy Hospital Kansas City, Mayo Clinic, University of Chicago, Massachusetts General Hospital
Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic Anemia
12/24
12/34
NCT05660785: Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia

Active, not recruiting
2
54
RoW
Herombopag, Cyclosporine A
Institute of Hematology & Blood Diseases Hospital, China, Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Non Severe Aplastic Anemia, Untreated
11/24
05/25
NCT05323617: Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy

Withdrawn
2
40
NA
Romiplostim, Nplate®, Antithymocyte Globulin, Cyclosporine A
Amgen
Severe Aplastic Anemia (SAA)
02/25
02/25
NCT01624805: Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome

Recruiting
2
140
US
Anti-Thymocyte Globulin, Antithymocyte Globulin, Antithymocyte Serum, ATG, ATGAM, ATS, Thymoglobulin, Cyclosporine, 27-400, Ciclosporin, CsA, Cyclosporin, Cyclosporin A, Gengraf, Neoral, OL 27-400, Sandimmun, Sandimmune, SangCya, Filgrastim, FILGRASTIM, LICENSE HOLDER UNSPECIFIED, G-CSF, Neupogen, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, rG-CSF, Tevagrastim, Methylprednisolone, Adlone, Caberdelta M, DepMedalone, Depo Moderin, Depo-Nisolone, Duralone, Emmetipi, Esametone, Firmacort, Medlone 21, Medrate, Medrol, Medrol Veriderm, Medrone, Mega-Star, Meprolone, Methylprednisolonum, Metilbetasone Solubile, Metrocort, Metypresol, Metysolon, Predni-M-Tablinen, Prednilen, Radilem, Sieropresol, Solpredone, Summicort, Urbason, Veriderm Medrol, Wyacort, Pegfilgrastim, Filgrastim SD-01, filgrastim-SD/01, Fulphila, HSP-130, Jinyouli, Neulasta, Neulastim, Pegfilgrastim Biosimilar HSP-130, SD-01, SD-01 sustained duration G-CSF
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome
06/26
06/26
RACE2, NCT05049668: RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial

Enrolling by invitation
N/A
197
Europe
ATGAM plus CsA with or without Eltrombopag, hATG+CsA +/- Revolade
European Group for Blood and Marrow Transplantation
Severe Aplastic Anemia
12/33
12/34

Download Options